Professional Documents
Culture Documents
2015 BY
RIGHTS RESERVED.
53
METHODS
THIS STUDY WAS APPROVED BY THE VARIOUS INSTITU-
RESULTS
A TOTAL OF 40 EYES OF 35 PATIENTS (15 MALE AND 20 FEMALE)
JANUARY 2015
Sex
Age
Eye
BCVA
(Onset)
1
2
3
M
F
F
64
81
57
OS CF
CF
OS CF
CF
OS 20/150 20/50
4
5
6
7
8
M
M
F
F
F
91
63
57
64
80
9
10
11
12
13
14
F
F
F
F
M
F
49
67
33
49
91
55
OD
OD
OS
OD
OS
OD
OD
OD
OD
OD
OS
OS
CF
20/300
20/400
20/200
20/80
20/50
20/20
20/50
20/20
20/40
20/20
CF
NLP
20/300
20/400
20/200
20/40
20/30
20/30
20/50
20/30
15
16
17
F
M
F
67
82
80
18
70
OS
OD
OS
OD
OD
CF
20/80
CF
20/25
20/150
CF
20/60
CF
20/25
20/40
19
17
OD 20/15
20
21
22
23
24
25
26
27
28
F
F
M
F
M
F
M
F
M
59
87
80
45
77
81
63
55
42
29
39
30
26
OD
OS
OS
OD
OD
OS
OD
OS
OD
OS
OD
OS
OD
31
51
32
33
34
35
M
M
M
M
55
67
58
44
20/20
20/50
CF
HM
HM
4/200
20/25
20/200
20/20
20/20
20/20
20/20
20/25
OD 20/20
20/200
OS 20/20
OS CF
OD 20/400
OD CF
BCVA
(Final)
Followup (Mo)
12
18
6
20/20
20/200
CF
20/400
Other Eye
Diseases
SCI/DCI
CRAO
CRAO
CRAO
SCIDCI
SCIDCI
SCIDCI CSC
120
8
9
7
24
24
44
4
46
0
0
0
CRAO
CRAO
CRAO
Cilioretinal AO
BRAO
BRAO
BRAO
BRAO
BRAO
BRAO
BRAO
CRAO
SCIDCI
SCIDCI
SCIDCI
SCIDCI
SCIDCI
SCIDCI
SCIDCI
SCIDCI
SCIDCI
SCIDCI
SCIDCI AMD
Only DCI
3
4
49
49
50
BRAO
BRAO
CRVOCRAO
BRAO
BRAO
SCIDCI
SCIDCI
SCIDCI
Only DCI
SCIDCI
BRAO
SCIDCI
0
9
2
25
27
8
1
11
62
62
11
11
5
BRAO
CRVOCRAO
CRVOCRAO
CRVOCRAO
CRVOCRAO
CRVOBRAO
CRVOBRAO
CRVOCRAO
BRAO
BRAO
BRAO
BRAO
BRAO
Only DCI
SCIDCI
SCIDCI
SCIDCI
SCIDCI
SCIDCI
SCIDCI
SCIDCI
SCIDCI
SCIDCI
SCIDCI
SCIDCI
Only DCI
4
6
0
80
1
0
BRAO
BRAO
Cilioretinal AO
Cilioretinal AO
CRAO
CRAO
Only DCI
SCIDCI RD, s/p PPV
Only DCI
Only DCI Macular hole
Only DCI
Only DCI
5/200
CF
HM
HM
4/200
20/25
20/100
20/20
20/20
20/20
20/20
20/25
Diagnosis
Systemic Diseases
HTN
HTN
Non Hodgkin lymphoma, DM, HTN, renal
failure, aortic atheroscleros, sleep apnea,
emphysema, anemia, DVT, sepsis
HTN
HTN
HTN, anemia
SLE 320 years
HTN
HTN, s/p aortic stent and bypass surgery
Left carotid dissection, left
parietal lobe embolic strokes
DM, RHD
POAG
HTN, renal failure, stroke
Ocular lymphoma, Multiple myeloma, non-Hodgkin
radiotherapy
lymphoma
NPDR,
HTN, DM, hypercholesterolemia,
macroaneurysm
arrhythmia/left bundle branch
block, mild erythrocytosis and
thrombocytosis 36 years
Prepapillary
vascular loop
Aortic calcifications
Rubeosis
HTN, Parkinson disease
Vasculitis
VSD
HTN
POAG
NPDR
NPDR
Vasculitis
Vasculitis
DM
AMD age-related macular degeneration; AO artery occlusion; BCVA best-corrected visual acuity; BRAO branch retinal artery occlusion;
CF counting fingers; CRAO central retinal artery occlusion; CRVO central retinal vein occlusion; CSC central serous chorioretinopathy; DCI
deep capillary ischemia; DM diabetes mellitus; DVT deep vein thrombosis; HTN hypertension; LP light perception; MI myocardial infarction;
N/A not applicable; NPDR nonproliferating diabetic retinopathy; POAG primary open-angle glaucoma; PPV pars plana vitrectomy; RHD
rheumatic heart disease; SCI superficial capillary ischemia; SLE systemic lupus erythematosus; s/p status post; VSD ventricular septal defect.
55
! CASE 2:
56
! CASE 3:
! CASE 4:
JANUARY 2015
FIGURE 1. Case 1: Multimodal imaging of an 80-year-old woman (Patient 8) with branch retinal artery occlusion (BRAO) in the left
eye (OS) showing both superficial and deep capillary ischemia and their evolution from the acute to chronic phase. (Top row, left)
Color fundus photograph at the acute phase showing retinal whitening and opacity along the superotemporal branch artery. (Top row,
second from left) Fluorescein angiography (FA) at the acute phase showing delayed perfusion of the superotemporal branch artery.
(Top row, third from left) Color fundus photograph at the chronic phase showing resolution of the retinal whitening. (Top right) FA
at the chronic phase showing no evidence of perfusion insufficiency. (Second row, left) Spectral-domain optical coherence tomography (SD OCT) in the acute phase through the ischemic area (green line in Top row, left image) showing thickening and hyperreflectivity of the inner and middle retinal layers owing to the presence of both superficial and deep capillary ischemia. (Second row, right)
SD OCT in the chronic phase through the ischemic area (green line in Top row, third from left image) showing subsequent thinning of
the inner and middle retinal layers. (Third row, left) SD OCT in the acute phase through the fovea, at the edge of the ischemic area
(yellow line in Top row, left image), showing thickening and hyperreflectivity of the middle retinal layers (arrows) referred to as paracentral acute middle maculopathy, indicating deep capillary ischemia. (Third row, right) SD OCT in the chronic phase through the
fovea, at the edge of the ischemic area (yellow line in Top row, third from left image) showing subsequent thinning of only the middle
retinal layers (arrows). (Bottom row, left) High magnification of the deep capillary ischemia in the acute phase showing thickening
and hyperreflectivity of the middle retinal layers (boxed in image above). (Bottom row, right) High magnification of the deep capillary
ischemia in the chronic phase showing thinning of the middle retinal layers (boxed in image above).
DISCUSSION
IN THIS STUDY, THE PRESENCE OF BOTH SUPERFICIAL AND
57
FIGURE 2. Case 2: Multimodal imaging of a 91-year-old man (Patient 13) with a history of nonexudative age-related macular degeneration (AMD) and new-onset branch retinal artery occlusion (BRAO) in the left eye (OS), showing both superficial and deep capillary ischemia in the acute phase. (Top row) Color fundus photograph and spectral-domain optical coherence tomography (SD OCT)
imaging taken 2 years prior to presentation showing normal retinal architecture except for a few drusen. (Second row, left) Color
fundus photograph taken at presentation showing mild retinal whitening along the inferotemporal branch retinal artery consistent
with a BRAO. (Second row, right) SD OCT imaging through the yellow line in the image on the left, showing an area of thickening
and hyperreflectivity of the inner retinal layers at the area closer to the optic nerve (yellow arrow). There is a separate area located
temporally that showed thickening and hyperreflectivity of both the inner and middle retinal layers (white arrow). (Bottom row, left)
Fluorescein angiography showing delayed filling in the inferotemporal branch retinal artery. (Bottom row, right) SD OCT imaging
through the yellow line in the image on the left, showing an area of superficial capillary ischemia (yellow arrow) and an area of superficial and deep capillary ischemia (white arrow).
JANUARY 2015
FIGURE 3. Case 3: Multimodal imaging of a 59-year-old woman (Patient 20) with a branch retinal artery occlusion in the right eye
(OD) showing isolated deep capillary ischemia. (Top row, left) Color fundus photograph showing mild retinal whitening inferotemporal to the central fovea, consistent with a BRAO. (Top row, right) Fluorescein angiography (FA) was normal and showed no evidence of perfusion insufficiency. (Second row, left) Magnified color photograph showing a Hollenhorst plaque (arrow). (Second row,
right) Magnified FA showing a subtle narrowing of the retinal vessel but no visible delay in filling. (Bottom) Spectral-domain optical
coherence tomography showing thickening and hyperreflectivity of the middle layers and paracentral middle maculopathy (arrows).
59
FIGURE 4. Case 4: Multimodal imaging of a 64-year-old woman (Patient 7) with cilioretinal artery occlusion in the right eye (OD)
showing both superficial and deep capillary ischemia in the acute phase. (Left) Color fundus photograph showing mild retinal whitening along the cilioretinal artery. (Right, top row) Near-infrared reflectance (NIR) and corresponding spectral-domain optical coherence tomography (SD OCT) through an area superior to the fovea showing normal reflectance and normal retinal structures. (Right,
middle row) NIR and corresponding SD OCT through the edge of ischemic whitening at the fovea showing a hyporeflective area on
NIR corresponding to paracentral acute middle maculopathy lesion on SD OCT, representing deep capillary ischemia. (Right, bottom
row) NIR and corresponding SD OCT through the center of retinal whitening inferior to the fovea showing the hyporeflective area on
NIR corresponding to thickening and hyperreflectively of the inner and middle retinal layers on SD OCT, representing superficial and
deep capillary ischemia.
FIGURE 5. Case 5: Multimodal imaging of an 81-year-old woman (Patient 2) with central retinal artery occlusion (CRAO) in the
left eye (OS) showing both superficial and deep capillary ischemia in the acute phase. (Top row, left) Color fundus photograph
showing the characteristic cherry-red spot appearance in acute CRAO. (Top row, right) Spectral-domain optical coherence tomography (SD OCT) through the fovea showing thickening and hyperreflectivity of the inner and middle retinal layers, indicating both
superficial and deep capillary ischemia. There is a hyperreflective quality at the central fovea at the level of the outer retinal layers,
retinal pigment epithelium, and choroid that may be related to a contrast effect elicited by transmission of incoming light at the fovea
and relative blocking of incoming light by the paracentral ischemic lesions. (Bottom row) Sequential fluorescein angiography showing
delayed filling in the retinal arterial circulation.
JANUARY 2015
FIGURE 6. Case 6: Multimodal imaging and carotid angiography of a 55-year-old woman (Patient 14) with carotid artery dissection
and central retinal artery occlusion (CRAO) in the left eye (OS) showing isolated paracentral acute middle maculopathy in the acute
phase. (Top row, left) Color fundus photograph was normal. (Top row, second from left) Fundus autofluorescence was normal. (Top
row, third from left) Fluorescein angiography (FA) was normal. (Top row, right) FA in the late phase showing no evidence of perfusion insufficiency. (Second row) Near-infrared reflectance (NIR) and corresponding spectral-domain optical coherence tomography
(SD OCT) through the fovea showing an area of hyporeflectance on NIR surrounding the fovea, corresponding to isolated paracentral
acute middle maculopathy lesion on SD OCT. (Third row) Magnified view of the SD OCT showing isolated paracentral acute middle
maculopathy surrounding the fovea, indicating isolated deep capillary ischemia. There is a hyperreflective quality at the central fovea
related to the contrast effect brought about by transmission of incoming light at the fovea and relative blocking of incoming light by the
paracentral acute middle maculopathy lesions. (Bottom row, left) Humphrey visual field test showing a normal visual field OD and a
central scotoma OS corresponding to the central ischemic lesion. (Bottom row, right) Carotid angiography showing a carotid dissection on the left side.
maculopathy but failed to note any cases with isolated superficial capillary ischemia. Isolated cotton-wool spots
may represent a different mechanism or level of occlusion
(ie, precapillary arteriolar occlusion or superficial capillary ischemia, as occurs with diabetic retinopathy).1 Our
inability to identify isolated superficial capillary ischemia
in association with retinal artery occlusion may be attributable to selection bias and/or to the limitations of a retrospective study. Other limitations of this study include the
small sample size and nonconsecutive series in which the
61
FIGURE 7. Summary of the spectrum of retinal capillary ischemic lesions seen with spectral-domain optical coherence tomography in
retinal arterial occlusive disease in the acute and chronic phase.
THE AUTHORS HAVE COMPLETED AND SUBMITTED THE ICMJE FORM FOR DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST.
Financial Disclosures: K. Bailey Freund: Consultant to Heidelberg Engineering, Regeneron, Genentech and Bayer HealthCare, and Thrombogenics. David
Sarraf: Speaker for Heidelberg and receives grant support from Regeneron. Brandon Lujan: Consultant to Genentech/Roche, Regeneron, Avalanche.
Lawrence A. Yannuzzi: Consultant to Genentech, Bayer, and Regeneron. Michael J. Cooney: Consultant to Bausch & Lomb; Speaker for Bausch &
Lomb, Genentech, and Regeneron. The Macula Foundation, Inc, New York, New York will provide financial support in relation to printing of the publication and has no role in the design or conduct of this study. Contributions of authors: design of the study (S.Y., C.E.P., K.B.F., D.S.); conduct of the study
(S.Y., C.E.P., Y.G., K.B.F., L.A.Y., E.R., B.J.L., H.T., M.J.C., D.S.); data collection (S.Y., C.E.P., Y.G., K.B.F., L.A.Y., E.R., B.J.L., H.T., M.J.C., D.S.); data
management (S.Y., C.E.P., Y.G., K.B.F., L.A.Y., E.R., B.J.L., H.T., M.J.C., D.S.); data analysis (S.Y., C.E.P., Y.G., K.B.F., L.A.Y., E.R., B.J.L., H.T., M.J.C.,
D.S.); interpretation of data (S.Y., C.E.P., Y.G., K.B.F., L.A.Y., E.R., B.J.L., H.T., M.J.C., D.S.); preparation of manuscript (S.Y., C.E.P., K.B.F., D.S.);
review of manuscript (S.Y., C.E.P., K.B.F., L.A.Y., E.R., B.J.L., H.T., M.J.C., D.S.); approval of manuscript (S.Y., C.E.P., Y.G., K.B.F., L.A.Y., E.R.,
B.J.L., H.T., M.J.C., D.S.).
REFERENCES
1. Yu S, Wang F, Pang CE, et al. Multimodal imaging findings in
retinal deep capillary ischemia. Retina 2014;34(4):636646.
2. Dorrell MI, Friedlander M, Smith LEH. Chapter 2. Retinal
vascular development. In: Joussen AM, Gardner TW,
62
JANUARY 2015
63
Biosketch
Suqin Yu, MD is a medical retina specialist. She received her medical degree from Shanghai Medical University and master
degree from Shanghai Medical College of Fudan University. Dr Yu is currently an Associate Professor of the Department of
Ophthalmology, Shanghai Jiaotong University affiliated Shanghai First Peoples Hospital, China.
63.e1
JANUARY 2015
Biosketch
Dr Claudine E. Pang graduated with Distinction from the National University of Singapore, completed ophthalmology
training with the Royal College of Surgeons in Edinburgh (FRSCEd) and College of Ophthalmologists, Academy of
Medicine in Singapore (FAMS). She has received 2 vitreoretinal fellowships at the Vitreous Retina Macula
Consultants of New York, Manhattan Eye, Ear and Throat Hospital, followed by the William H. Ross Vitreoretinal
Surgical Fellowship at the University of British Columbia, Vancouver. Her interests are in macular diseases,
vitreomacular surgery and retinal imaging.
63.e2